BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32179749)

  • 1. Chromatin accessibility promotes hematopoietic and leukemia stem cell activity.
    Cabal-Hierro L; van Galen P; Prado MA; Higby KJ; Togami K; Mowery CT; Paulo JA; Xie Y; Cejas P; Furusawa T; Bustin M; Long HW; Sykes DB; Gygi SP; Finley D; Bernstein BE; Lane AA
    Nat Commun; 2020 Mar; 11(1):1406. PubMed ID: 32179749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal protein HMGN1 enhances the acetylation of lysine 14 in histone H3.
    Lim JH; West KL; Rubinstein Y; Bergel M; Postnikov YV; Bustin M
    EMBO J; 2005 Sep; 24(17):3038-48. PubMed ID: 16096646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells.
    Gao XN; Lin J; Ning QY; Gao L; Yao YS; Zhou JH; Li YH; Wang LL; Yu L
    PLoS One; 2013; 8(2):e55481. PubMed ID: 23390536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
    Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG
    Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression.
    Mowery CT; Reyes JM; Cabal-Hierro L; Higby KJ; Karlin KL; Wang JH; Kimmerling RJ; Cejas P; Lim K; Li H; Furusawa T; Long HW; Pellman D; Chapuy B; Bustin M; Manalis SR; Westbrook TF; Lin CY; Lane AA
    Cell Rep; 2018 Nov; 25(7):1898-1911.e5. PubMed ID: 30428356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZMYND11-MBTD1 induces leukemogenesis through hijacking NuA4/TIP60 acetyltransferase complex and a PWWP-mediated chromatin association mechanism.
    Li J; Galbo PM; Gong W; Storey AJ; Tsai YH; Yu X; Ahn JH; Guo Y; Mackintosh SG; Edmondson RD; Byrum SD; Farrar JE; He S; Cai L; Jin J; Tackett AJ; Zheng D; Wang GG
    Nat Commun; 2021 Feb; 12(1):1045. PubMed ID: 33594072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs.
    Maiques-Diaz A; Chou FS; Wunderlich M; Gómez-López G; Jacinto FV; Rodriguez-Perales S; Larrayoz MJ; Calasanz MJ; Mulloy JC; Cigudosa JC; Alvarez S
    Leukemia; 2012 Jun; 26(6):1329-37. PubMed ID: 22289984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.
    Ptasinska A; Assi SA; Mannari D; James SR; Williamson D; Dunne J; Hoogenkamp M; Wu M; Care M; McNeill H; Cauchy P; Cullen M; Tooze RM; Tenen DG; Young BD; Cockerill PN; Westhead DR; Heidenreich O; Bonifer C
    Leukemia; 2012 Aug; 26(8):1829-41. PubMed ID: 22343733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal protein HMGN1 enhances the heat shock-induced remodeling of Hsp70 chromatin.
    Belova GI; Postnikov YV; Furusawa T; Birger Y; Bustin M
    J Biol Chem; 2008 Mar; 283(13):8080-8. PubMed ID: 18218636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential niche and Wnt requirements during acute myeloid leukemia progression.
    Lane SW; Wang YJ; Lo Celso C; Ragu C; Bullinger L; Sykes SM; Ferraro F; Shterental S; Lin CP; Gilliland DG; Scadden DT; Armstrong SA; Williams DA
    Blood; 2011 Sep; 118(10):2849-56. PubMed ID: 21765021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal protein HMGN1 modulates histone H3 phosphorylation.
    Lim JH; Catez F; Birger Y; West KL; Prymakowska-Bosak M; Postnikov YV; Bustin M
    Mol Cell; 2004 Aug; 15(4):573-84. PubMed ID: 15327773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of active chromatin states by HMGN2 is required for stem cell identity in a pluripotent stem cell model.
    Garza-Manero S; Sindi AAA; Mohan G; Rehbini O; Jeantet VHM; Bailo M; Latif FA; West MP; Gurden R; Finlayson L; Svambaryte S; West AG; West KL
    Epigenetics Chromatin; 2019 Dec; 12(1):73. PubMed ID: 31831052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated transcriptomic and epigenetic data analysis identifiesaberrant expression of genes in acute myeloid leukemia with MLL‑AF9 translocation.
    Wang F; Li Z; Wang G; Tian X; Zhou J; Yu W; Fan Z; Dong L; Lu J; Xu J; Zhang W; Liang A
    Mol Med Rep; 2020 Feb; 21(2):883-893. PubMed ID: 31789407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiling of HMGN1 reveals an association with chromatin at regulatory regions.
    Cuddapah S; Schones DE; Cui K; Roh TY; Barski A; Wei G; Rochman M; Bustin M; Zhao K
    Mol Cell Biol; 2011 Feb; 31(4):700-9. PubMed ID: 21173166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
    Korthuis PM; Berger G; Bakker B; Rozenveld-Geugien M; Jaques J; de Haan G; Schuringa JJ; Vellenga E; Schepers H
    Leukemia; 2015 Mar; 29(3):625-35. PubMed ID: 25184385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal protein HMGN1 modulates the phosphorylation of serine 1 in histone H2A.
    Postnikov YV; Belova GI; Lim JH; Bustin M
    Biochemistry; 2006 Dec; 45(50):15092-9. PubMed ID: 17154547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.
    Stavropoulou V; Kaspar S; Brault L; Sanders MA; Juge S; Morettini S; Tzankov A; Iacovino M; Lau IJ; Milne TA; Royo H; Kyba M; Valk PJM; Peters AHFM; Schwaller J
    Cancer Cell; 2016 Jul; 30(1):43-58. PubMed ID: 27344946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
    Chen Y; Ernst P
    Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal protein HMGN1 modulates the expression of N-cadherin.
    Rubinstein YR; Furusawa T; Lim JH; Postnikov YV; West KL; Birger Y; Lee S; Nguyen P; Trepel JB; Bustin M
    FEBS J; 2005 Nov; 272(22):5853-63. PubMed ID: 16279949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.